Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L James Tyree


  • Director at Chemocentryx Inc. (CCXI), 2019-05-24
  • Director at Assertio Therapeutics Inc (ASRT), 2019-05-09
  • Director at Innoviva Inc. (INVA), 2017-04-24
  • Officer at Abbott Laboratories (ABT), 2009-03-03
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CCXI $4.39 5,544 Director 20,575 2016-05-23 Filing
INVA $10.47 813 Director 50,697 2016-05-18 Filing
THRX $16.85 2,438 Director 33,182 2015-06-02 Filing
CCXI $7.45 12,703 Director 14,324 2015-05-22 Filing
ABT $47.72 500 Officer 132,176 2009-02-27 Filing